SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
GENOMIC HEALTH
(NQNM:GHDX Last Sale: 34.17 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (GHDX : $34.17)
$975 million Market Cap at September 12, 2013
Employs 100.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
301 Penobscot Drive Research Report Earnings Snapshot - Last 11/04/18
Redwood City, CA 94063 Fact Sheet
Phone: (650) 556-9300 Financial Statements
Peer Comparison
Annual Reports

Randal W. Scott, Co-Founder/Chmn./CEO, Kimberly Popovits, Pres./COO, G. Bradley Cole, CFO
Diagnostic tests. First commercial test is focused on patients with early stage, node negative, or N-, estrogen receptor positive, or ER+, breast cancer who will be treated with hormonal therapy. IPO at $12 September 28, 2005. Raised $60.2 million, selling 5 million shares, 21% of the outstanding. Lead Manager: J.P. Morgan.
Historical Charts    Technical Analysis
No Historical Data available for GHDX

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common GHDX $34.17 $ 0 $33.86 $34.61 105,649 $25.25 $38.99 28,531
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $974,904

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex